Device therapy for patients with atrial fibrillation and heart failure with preserved ejection fraction.
Ontology highlight
ABSTRACT: Device therapy is a nonpharmacological approach that presents a crucial advancement for managing patients with atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF). This review investigated the impact of device-based interventions and emphasized their potential for optimizing treatment for this complex patient demographic. Cardiac resynchronization therapy, augmented by atrioventricular node ablation with His-bundle pacing or left bundle-branch pacing, is effective for enhancing cardiac function and establishing atrioventricular synchrony. Cardiac contractility modulation and vagus nerve stimulation represent novel strategies for increasing myocardial contractility and adjusting the autonomic balance. Left ventricular expanders have demonstrated short-term be
SUBMITTER: Zhang Z
PROVIDER: S-EPMC10943171 | biostudies-literature | 2024 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA